Ludwig Jeffrey Jerome 4
4 · PUMA BIOTECHNOLOGY, INC. · Filed Mar 15, 2022
Insider Transaction Report
Form 4
Ludwig Jeffrey Jerome
Chief Commercial Officer
Transactions
- Award
Common Stock
2022-03-03+39,118→ 70,460 total - Award
Stock Option (Right to Buy)
2022-03-03+55,882→ 55,882 totalExercise: $2.33Exp: 2032-03-02→ Common Stock (55,882 underlying)
Footnotes (2)
- [F1]Subject to the Grantee's continued service with the Company through the applicable vesting date, the Restricted Stock Units shall vest with respect to one-fourth (1/4th) of the Restricted Stock Units on each of July 1, 2022, January 1, 2023, July 1, 2023 and January 1, 2024.
- [F2]Subject to the Optionee's continued service with the Company through the applicable vesting date, the Option shall vest and become exercisable with respect to one-fourth (1/4th) of the Shares subject thereto on each of July 1, 2022, January 1, 2023, July 1, 2023 and January 1, 2024.